A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China
Latest Information Update: 19 Jun 2024
At a glance
- Drugs Zirconium silicate (Primary)
- Indications Hyperkalaemia
- Focus Adverse reactions
- Acronyms ACTUALIZE
- Sponsors AstraZeneca
Most Recent Events
- 14 Jun 2024 Status changed from recruiting to completed.
- 24 Oct 2023 Planned End Date changed from 31 Jan 2024 to 8 Jun 2024.
- 24 Oct 2023 Planned primary completion date changed from 31 Jan 2024 to 8 Jun 2024.